全文获取类型
收费全文 | 2874篇 |
免费 | 177篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 82篇 |
妇产科学 | 57篇 |
基础医学 | 441篇 |
口腔科学 | 77篇 |
临床医学 | 396篇 |
内科学 | 650篇 |
皮肤病学 | 51篇 |
神经病学 | 312篇 |
特种医学 | 51篇 |
外科学 | 249篇 |
综合类 | 18篇 |
一般理论 | 1篇 |
预防医学 | 263篇 |
眼科学 | 58篇 |
药学 | 153篇 |
中国医学 | 9篇 |
肿瘤学 | 182篇 |
出版年
2023年 | 13篇 |
2022年 | 55篇 |
2021年 | 69篇 |
2020年 | 41篇 |
2019年 | 61篇 |
2018年 | 70篇 |
2017年 | 52篇 |
2016年 | 63篇 |
2015年 | 103篇 |
2014年 | 125篇 |
2013年 | 143篇 |
2012年 | 203篇 |
2011年 | 214篇 |
2010年 | 97篇 |
2009年 | 107篇 |
2008年 | 199篇 |
2007年 | 179篇 |
2006年 | 168篇 |
2005年 | 164篇 |
2004年 | 198篇 |
2003年 | 165篇 |
2002年 | 172篇 |
2001年 | 20篇 |
2000年 | 20篇 |
1999年 | 23篇 |
1998年 | 31篇 |
1997年 | 40篇 |
1996年 | 17篇 |
1995年 | 24篇 |
1994年 | 19篇 |
1993年 | 19篇 |
1992年 | 17篇 |
1991年 | 8篇 |
1990年 | 14篇 |
1989年 | 13篇 |
1988年 | 8篇 |
1987年 | 16篇 |
1986年 | 13篇 |
1985年 | 13篇 |
1984年 | 10篇 |
1983年 | 7篇 |
1982年 | 6篇 |
1981年 | 8篇 |
1980年 | 6篇 |
1979年 | 4篇 |
1978年 | 10篇 |
1974年 | 6篇 |
1972年 | 3篇 |
1971年 | 3篇 |
1967年 | 3篇 |
排序方式: 共有3056条查询结果,搜索用时 15 毫秒
21.
Patrice Hermann Dominique Blanchard Blandine de Saint-Vis Franois Fossiez Claude Gaillard BAtrice Vanbervliet Francine Brire Jacques Banchereau Jean-Pierre Galizzi 《European journal of immunology》1993,23(4):961-964
To identify the ligand(s) of the human CD40 antigen, a cDNA encoding the extracellular domain of the CD40 antigen was fused to a cDNA encoding the constant region (Fc) of human IgGl. The CD40-Fc fusion protein was able to specifically bind to CD4+ and various CD8+ T cell clones activated with immobilized anti-CD3. The 125I-labeled CD40-Fc fusion protein bound anti-CD3 activated CD4+ T cell clone (MT9) with an equilibrium dissociation constant (Ka) of 10-20 nM. The human CD40-binding protein expressed on the cell surface of activated T lymphocytes is a monomeric protein of ≈ 32 kDa. Minor components of 29 kDa and 17 kDa were also detected. A small proportion of CD4+ and CD8+ blood mononuclear T cells activated by anti-CD3 expressed the CD40 ligand but its detection was best observed following depletion of B cells. Addition of B cells to purified T cells abolished the binding of CD40-Fc obtained after anti-CD3 activation. 相似文献
22.
Willis F Graff-Radford N Pinto M Lawson L Adamson J Epstein D Parfitt F Hutton M O'Brien PC 《Journal of the National Medical Association》2003,95(1):71-76
Through its role in lipid metabolism, Apolipoprotein epsilon4 (ApoE4) may affect "brain repair" in stroke, brain hemorrhage, Alzheimer's disease, and other brain injury syndromes for which African Americans may have greater morbidity and mortality. Cross-cultural evaluations of these and other genetic factors may provide insight on possible ethnic differences in risk of morbidity to acute central nervous system (CNS) injury and chronic neurodegenerative processes. As an initial step toward expanding knowledge of ApoE allele frequencies for persons of African descent, we compared ApoE genotype of a group of 70 young Ugandans to 59 (subset of a larger group of 342 African Americans of all ages) age-matched African Americans and to published frequencies for Caucasians and Asians. We found that the ApoE4 and epsilon2 alleles are more frequent in Ugandans (U) than Caucasians (C) or Asians (A) with corresponding alleles showing significant elevations of epsilon2 (U 15.71%, C 8.40%, A 4.20%) and 14 (U 25%, C 13.70%, A 8.90%) (p < .001). Comparing the differences between Ugandans and age-appropriate African Americans (AA) was not statically significant, but this outcome may be due to small sample size. These results provide the only published ApoE frequencies for Ugandans and the complete set of data provides the largest published community group of ApoE frequencies for African Americans. 相似文献
23.
Origin and filiation of human plasmacytoid dendritic cells 总被引:8,自引:0,他引:8
Brière F Bendriss-Vermare N Delale T Burg S Corbet C Rissoan MC Chaperot L Plumas J Jacob MC Trinchieri G Bates EE 《Human immunology》2002,63(12):1081-1093
Human plasmacytoid dendritic cells represent a rare population of leukocytes which produce high amounts of type I interferon in response to certain viruses. Although those cells were first described in 1958, there are still unsolved issues related to their origin and function. Recently, a leukemic counterpart of plasmacytoid dendritic cells was identified. Molecular approaches using either normal or leukemic plasmacytoid dendritic cells provide some new insights into the controversial lymphoid origin of those cells. The need for specific markers is still a critical aspect for the identification of plasmacytoid dendritic cells, whatever stage of differentiation, in normal as well as in pathological conditions. Hopefully, novel markers will allow delineation of the relationships between dendritic cells at different stages of differentiation/maturation along the myeloid and lymphoid lineages. 相似文献
24.
Agns Buzyn Marina Ostankovitch Anne Zerbib Mathilde Kemula Francine Connan Bruno Varet Jean-Grard Guillet Jeannine Choppin 《European journal of immunology》1997,27(8):2066-2072
Chronic myeloid leukemia (CML) is characterized cytogenetically by a t(9;22) translocation which generates a hybrid bcr-abl gene, encoding a p210bcr-abl fusion protein. The induction in vitro of leukemia-specific T cells reactive with p210bcr-abl is a strategy developed for an immunological therapeutic approach in CML. Peptides from the junction region of this chimeric protein have been considered as potential targets for a cytotoxic response against leukemic cells. However, only a few peptides encompassing the two p210bcr-abl breakpoints have been shown to bind to the most common HLA class I molecules, which limits the number of patients who could benefit from this approach. We assume that the presence of chimeric BCR-ABL protein in leukemic cells may affect processing and delivery of peptides, possibly giving rise to new epitopes at the cell surface. We selected 162 peptides from the whole sequence of this protein, including 14 peptides of the b2a2 and b3a2 junctions, which had an anchor motif for a common HLA class I molecule. We tested their ability to bind to eight HLA class I molecules (HLA-A1, -A2, -A3, -A11, -B7, -B8, -B27, -B44). We identified 48 peptides from outside the junction region, with intermediate or strong binding capacities to these HLA class I molecules contrasting with only six junction peptides with a moderate binding capacity to HLA-A3/A11, -B8, or -B44 molecules. Moreover, cytotoxic T lymphocyte lines specific for various peptides outside the junction were generated from peripheral blood mononuclear cells of HLA-A2 or -B7 healthy donors and from one CML patient. These results contribute to evaluation of immunity to the BCR-ABL chimeric protein. Further studies are required to investigate whether such epitopes are correctly processed and presented by leukemic cells. 相似文献
25.
Bendriss-Vermare N Burg S Kanzler H Chaperot L Duhen T de Bouteiller O D'agostini M Bridon JM Durand I Sederstrom JM Chen W Plumas J Jacob MC Liu YJ Garrone P Trinchieri G Caux C Brière F 《Journal of leukocyte biology》2005,78(4):954-966
Depending on the activation status, plasmacytoid dendritic cells (PDC) and myeloid DC have the ability to induce CD4 T cell development toward T helper cell type 1 (Th1) or Th2 pathways. Thus, we tested whether different activation signals could also have an impact on the profile of chemokines produced by human PDC. Signals that induce human PDC to promote a type 1 response (i.e., viruses) and a type 2 response [i.e., CD40 ligand (CD40L)] also induced PDC isolated from tonsils to secrete chemokines preferentially attracting Th1 cells [such as interferon-gamma (IFN-gamma)-inducible protein (IP)-10/CXC chemokine ligand 10 (CXCL10) and macrophage inflammatory protein-1beta/CC chemokine ligand 4 (CCL4)] or Th2 cells (such as thymus and activation-regulated chemokine/CCL17 and monocyte-derived chemokine/CCL22), respectively. Activated natural killer cells were preferentially recruited by supernatants of virus-activated PDC, and supernatants of CD40L-activated PDC attracted memory CD4(+) T cells, particularly the CD4(+)CD45RO(+)CD25(+) T cells described for their regulatory activities. It is striking that CD40L and virus synergized to trigger the production of IFN-gamma by PDC, which induces another Th1-attracting chemokine monokine-induced by IFN-gamma/CXCL9 and cooperates with endogenous type I IFN for IP-10/CXCL10 production. In conclusion, our studies reveal that PDC participate in the selective recruitment of effector cells of innate and adaptive immune responses and that virus converts the CD40L-induced Th2 chemokine patterns of PDC into a potent Th1 mediator profile through an autocrine loop of IFN-gamma. 相似文献
26.
Dudal S Krzywkowski P Paquette J Morissette C Lacombe D Tremblay P Gervais F 《Neurobiology of aging》2004,25(7):861-871
Alzheimer's disease (AD) is characterized by a progressive cognitive decline leading to dementia and involves the deposition of amyloid-beta (Abeta) peptides into senile plaques. Other neuropathological features that accompany progression of the disease include a decrease in synaptic density, neurofibrillary tangles, dystrophic neurites, inflammation, and neuronal cell loss. In this study, we report the early kinetics of brain amyloid deposition and its associated inflammation in an early onset transgenic mouse model of AD (TgCRND8) harboring the human amyloid precursor protein gene with the Indiana and Swedish mutations. Both diffuse and compact plaques were detected as early as 9-10 weeks of age. Abeta-immunoreactive (Abeta-IR) plaques (4G8-positive) appeared first in the neocortex and amygdala, then in the hippocampal formation, and lastly in the thalamus. Compact plaques (ThioS-positive) with an amyloid core were observed as early as diffuse plaques were detected, but in lower numbers. Amyloid deposition increased progressively with age. The formation of plaques was concurrent with the appearance of activated microglial cells and shortly followed by the clustering of activated astrocytes around plaques at 13-14 weeks of age. This TgCRND8 mouse model allows for a rapid, time-dependent study of the relationship between the fibrillogenic process and the inflammatory response during the brain amyloidogenic process. 相似文献
27.
do Amaral Leandro Custódio Reis Baltazar Leão Ribeiro-Oliveira Antônio da Silva Santos Thamires Marx Giannetti Alexandre Varella 《Neurosurgical review》2021,44(3):1687-1702
Neurosurgical Review - A preferred treatment for residual/recurrent pituitary adenomas has not been established. The existence of higher complication rates for revision surgeries remains under... 相似文献
28.
29.
30.